YOSEMITE and RHINE - Eter, Nicole; Singh, Rishi P.; Abreu, Francis; Asik, Kemal; Basu, Karen; Baumal, Caroline; Chang, Andrew; Csaky, Karl G.; Haskova, Zdenka; Lin, Hugh; Ruiz, Carlos Quezada; Ruamviboonsuk, Paisan; et al. (Ophthalmology science (Online), 2022)
Keywords: Adjustable dosing; Angiopoietin-2; Anti–vascular endothelial growth factor; Bispecific antibody; Diabetic macular edema; Faricimab; Personalized treatment interval; Phase 3 clinical trial design; FFA; AE; PTI; CST; ETDRS; VEGF; Diabetic macular edema; ITT; Angiopoietin-2; Bispecific antibody; Phase 3 clinical trial design; CFP; Anti–vascular endothelial growth factor; PRN; DR; Personalized treatment interval; SD; IxRS; T&E; BCVA; CRC; Faricimab; Adjustable dosing; DME